Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Alberta

$438,708.00

Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis

FY 2011-12

Summary
This proposal stems from our recent observations that muscle wasting is common in people with cancer. Often, muscle loss associates with increased content of fat in muscle. Each of these features is related to morbidity and survival in people with cancer. Here, we propose new basic research to understand the biological causes of muscle wasting, as well as propose an intervention to modify muscle loss and fat in muscle. Two questions will be explored. The first of these relates to the reasons for muscle loss and replacement of the muscle tissue by fat tissue. This may be due to alterations in the muscle cells responsible for regeneration and renewal of muscle, or changes in the signals that govern muscle cell or fat cell growth. The second question relates to the ability of a nutritional intervention containing fats thought to be important for muscle health to reduce the loss of muscle and fat within the muscle tissue. Reasons for the benefits will be explored.
Program
Operating Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
239577
Name
Mazurak Vera C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$438,708
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Adipogenesis; Essential Fatty Acids; Lipid Metabolism; Muscle Health; Myosteatosis; Nutrient Requirements; Satellite Cells
Abstract
This proposal stems from our recent observations that muscle wasting is common in people with cancer. Often, muscle loss associates with increased content of fat in muscle. Each of these features is related to morbidity and survival in people with cancer. Here, we propose new basic research to understand the biological causes of muscle wasting, as well as propose an intervention to modify muscle loss and fat in muscle. Two questions will be explored. The first of these relates to the reasons for muscle loss and replacement of the muscle tissue by fat tissue. This may be due to alterations in the muscle cells responsible for regeneration and renewal of muscle, or changes in the signals that govern muscle cell or fat cell growth. The second question relates to the ability of a nutritional intervention containing fats thought to be important for muscle health to reduce the loss of muscle and fat within the muscle tissue. Reasons for the benefits will be explored.
Competitiondate
201109
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mazurak, Vera C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $438,708~ $0~